Assault by drugs, medicaments and biological substances

VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X85 Cause of death: ICD-10 — X85 2 out of 7 registries used, show all original rules.	59
4. Check minimum number of events None	59
5. Include endpoints None	59
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Control exclude: VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X85-Y09

NAME	VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST
CONTROL_EXCLUDE	VWXY20_ASSAULT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X85
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X85
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Assault by drugs, medicaments and biological substances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	29	26
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	39.59	42.27	36.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
59: Matched controls
590

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X85.9

ICD-10 Finland

Assault by drugs, medicaments and biological substances by unknown person

+∞

47.4

T74.1

ICD-10 Finland

Physical abuse

77.8

15.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

9.4

14.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

16.1

12.2

X85.0

ICD-10 Finland

Assault by drugs, medicaments and biological substances by spouse or partner

+∞

11.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

21.1

11.7

S06.0

ICD-10 Finland

Concussion

10.2

9.8

Y09

ICD-10 Finland

Assault by unspecified means

+∞

9.6

Y07

ICD-10 Finland

Other maltreatment

+∞

8.5

P15

ICPC

Chronic alcohol abuse

18.9

7.6

N05BA01

ATC

diazepam; systemic, rectal

5.7

7.5

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

16.5

7.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.3

7.0

N05AH04

ATC

quetiapine; oral

4.3

6.6

SPAT1263

SPAT

Sampling

4.1

6.5

156

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.4

6.4

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

+∞

6.4

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

+∞

6.4

X58

ICD-10 Finland

Exposure to other specified factors

4.5

6.2

N06AB04

ATC

citalopram; systemic

4.2

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001926) Buprenorphine [Presence] in Urine by Screen method

8.37

6.51

2.8

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

17.33

6.12

1.0

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

165

3.50

5.30

11.9

9.7

1.02

1.12

inr

—

(3016879) Cocaine [Presence] in Urine

5.78

5.09

2.8

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

8.34

4.88

3.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

6.26

4.76

3.7

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

5.07

4.59

2.8

1.2

—

(3027008) Opiates [Presence] in Urine

5.07

4.59

2.8

1.2

—

(3028300) Cannabinoids [Presence] in Urine

5.07

4.59

2.8

1.2

—

(3027944) Amphetamines [Presence] in Urine

4.91

4.48

2.8

1.2

—

(3042936) Bacteria identified in Isolate by Culture

3.68

4.03

2.0

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3.10

3.94

3.8

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

198

2.69

3.39

7.7

7.2

1.18

1.21

mmol/l

2.25

173

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

207

2.70

3.38

4.0

2.3

—

(3023368) Bacteria identified in Blood by Culture

2.84

3.34

5.9

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

130

2.60

3.07

4.0

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.82

2.92

6.9

3.7

483.25

84.84

ng/l

—

(3026008) Bacteria identified in Urine by Culture

105

2.55

2.75

3.0

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

5.14

2.68

1.1

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.23

2.57

2.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4.81

2.56

1.4

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.33

2.42

2.3

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

119

2.35

2.39

2.1

2.2

0.40

0.16

e6/l

0.29

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.56

2.15

3.6

1.5

—

(40768804) Tissue Pathology biopsy report

186

2.10

2.03

2.2

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

4.05

1.99

1.8

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

121

2.14

1.91

2.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.53

1.89

2.2

1.8

—

(40768797) Stomach Pathology biopsy report

2.45

1.88

1.1

1.3

—

(3019225) pH of Specimen

3.03

1.87

4.3

6.3

—

(36304419) Bacteria [Presence] in Urine

124

2.08

1.78

2.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4.10

1.75

6.0

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

142

2.02

1.73

2.7

1.9

85.55

99.96

pmol/l

0.99

(3004119) Hemoglobin [Mass/volume] in Venous blood

3.03

1.71

4.1

4.2

132.43

127.96

g/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.11

1.65

2.0

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.80

1.65

2.4

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.80

1.65

2.0

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3.06

1.55

2.2

4.4

26.40

24.01

mmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

134

1.88

1.40

2.3

2.2

8.36

20.65

e6/l

0.79

109

(3018095) Leukocytes [#/volume] in Urine

160

1.84

1.40

2.7

13.25

42.72

e6/l

0.62

118

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.03

1.39

3.3

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.04

1.35

1.4

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.94

1.31

1.2

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.94

1.31

15.8

7.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.25

1.31

2.0

1.5

—

(3012544) pH of Venous blood

2.41

1.30

4.0

3.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

149

1.76

1.19

2.5

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.63

1.17

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

116

1.79

1.14

2.3

1.5

—

(40758558) Short blood count panel - Blood

117

1.77

1.10

8.2

7.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

326

1.70

1.06

5.4

3.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.88

1.06

3.2

2.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.39

1.05

1.4

1.3

65.70

66.87

g/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.98

1.04

2.3

7.2

105.44

104.20

mmol/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.98

1.04

2.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.98

1.04

2.2

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

462

2.06

1.04

13.8

9.5

94.87

90.30

ml/min/173m2

1.17

373

(3041096) Erythrocytes [Presence] in Urine by Automated

137

1.70

1.02

2.3

—

(3033658) Prothrombin time (PT) actual/Normal

120

1.72

1.01

4.5

3.1

91.61

94.21

0.16

120

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2.07

1.01

1.9

3.6

6.07

5.51

kpa

—

(3025941) Bacteria identified in Stool by Culture

2.36

0.96

2.2

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

158

1.63

0.93

4.4

2.9

61.65

29.44

ng/l

0.28

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

186

1.60

0.92

4.3

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.78

0.86

1.8

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.77

0.82

2.4

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.86

0.81

3.2

7.0

1.02

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.78

0.79

1.4

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

249

1.52

0.78

8.2

6.4

—

(4035726) Immunohistochemistry procedure

1.95

0.77

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.01

0.72

1.2

2.1

—

(3022145) Colonoscopy Study observation

1.67

0.68

1.6

1.5

—

(40761535) Cells panel - Urine sediment

1.79

0.65

2.4

3.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.69

0.65

2.1

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.56

0.64

1.3

1.2

1.22

3.28

u/ml

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

171

1.46

0.62

6.6

3.6

33.36

30.75

u/l

0.30

164

(3007164) IgA [Mass/volume] in Serum or Plasma

121

1.44

0.51

1.3

1.5

1.92

2.46

g/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

236

1.35

0.48

5.4

3.8

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

238

1.34

0.45

4.4

2.7

0.00

estimate

—

(3019060) Gas panel - Arterial blood

1.67

0.44

13.2

7.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.67

0.44

2.2

2.6

5.04

5.32

kpa

—

(3009261) Glucose [Presence] in Urine by Test strip

240

1.32

0.42

4.4

2.8

0.00

estimate

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.42

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.42

0.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.42

0.0

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

3.1

—

1.47

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.40

0.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

1.4

2.1

—

(3012516) Albumin [Mass/volume] in Urine

111

1.34

0.34

2.9

3.4

4.70

56.61

mg/l

—

(3013512) EKG study

102

1.35

0.33

3.8

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

124

1.28

0.27

6.1

2.9

0.00

estimate

—

(4200892) Spirometry reversibility

1.38

0.24

1.4

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.31

0.23

3.4

3.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

117

1.26

0.23

3.7

3.6

1.16

7.19

mg/mmol

—

(3044889) 12 lead EKG panel

323

1.21

0.23

4.5

3.2

—

(1761868) Lipid panel - Serum or Plasma

205

0.82

0.21

2.9

2.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

3.3

—

3.52

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

3.5

—

55.09

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

414

0.83

0.21

3.1

3.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

56.76

—

(3002256) Pathology report gross observation

1.20

0.20

1.0

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.17

0.20

1.7

2.2

332.50

395.72

nmol/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.15

0.16

3.7

2.5

0.82

0.83

mmol/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

502

1.30

0.16

4.9

4.0

2.91

2.89

mmol/l

0.06

479

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.80

0.08

1.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.80

0.08

4.0

2.1

0.60

0.67

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.04

0.07

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

120

0.90

0.05

5.5

3.2

1.31

1.52

ug/l

0.25

110

(3003338) MCHC [Mass/volume]

473

0.97

0.00

25.6

13.7

333.04

333.75

g/l

0.18

473

(3003694) ABO and Rh group [Type] in Blood

135

1.05

0.00

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

104

0.95

0.00

7.4

3.0

—

(36660697) Celiac disease serology panel - Serum

0.96

0.00

1.2

—

(21494755) Public health laboratory ask at order entry panel

1.00

0.00

1.1

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

-0.00

0.0

2.1

—

4.00

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

76.80

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.6

—

12.02

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.5

—

(3000492) Spirometry study

1.00

-0.00

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

3.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.02

-0.00

8.4

8.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

2.1

—

76.28

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

32.67

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

-0.00

0.0

2.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.8

—

94.33

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

7.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.0

—

8.54

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.9

—

16.50

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

1.83

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

3.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST – Assault by drugs, medicaments and biological substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Assault by drugs, medicaments and biological substances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Assault by drugs, medicaments and biological substances (VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints